| Line Item | Aug 31, 2026 | May 31, 2026 | Feb 28, 2026 | Nov 30, 2025 | Aug 31, 2025 | May 31, 2025 | Feb 28, 2025 | Nov 30, 2024 | Aug 31, 2024 | May 31, 2024 | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | ||||||||||||||||
| Exploration expenses | ||||||||||||||||
| Foreign exchange loss/(gain) | ||||||||||||||||
| General and administrative | ||||||||||||||||
| Investor relations | ||||||||||||||||
| Professional fees | ||||||||||||||||
| Salaries | ||||||||||||||||
| Salaries and directors expense - stock-based compensation (note 6) | ||||||||||||||||
| Total expenses | ||||||||||||||||
| Other items | ||||||||||||||||
| Interest and other income | ||||||||||||||||
| Share of loss on equity investment (note 3(b)) | ||||||||||||||||
| Gain on derivative at fair market value (note 7) | — | |||||||||||||||
| Net Income/(loss) and comprehensive loss for the period | ||||||||||||||||
| Basic loss per common share | ||||||||||||||||
| Diluted loss per common share |